SOPHiA GENETICS and Strand Life Sciences enter partnership (NASDAQ:SOPH)
Press Room
Cloud-native software company SOPHiA GENETICS (NASDAQ:SOPH) partnered with Strand Life Sciences, a bioinformatics and diagnostics provider, to deliver innovative solutions that will fuel the use of precision medicine globally.
The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics technologies, cutting-edge bioinformatics services and innovative diagnostics solutions.
The two companies will use their bioinformatics expertise to expand the ability to accurately analyze key healthcare data and facilitate the use of data-driven decision-making globally.
